NL-OMON37878招募中不适用
Human short chain fatty acid metabolism and microbiota - Human SCFA metabolism
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients undergoing pylorus preserving pancreactico duodenectomy
- •18 < Age < 75 years old
排除标准
- •Ileo- or colostomy
- •Parenchymal and/or inflammatory liver disease
- •Steroid hormone medication
- •n-acetyl cystein medication
- •Lactation, pregnancy and planning of pregnancy
- •Inflammatory bowel disease
- •Coagulation disorders
- •Excessive drinking (>20 alcoholic consumptions per week) and/or smoking
- •Inborn errors of metabolism (liver enzyme deficiencies)
- •Use of antibiotics during and 3 months prior to the study
- •Pre-and probiotic use during and 3 months prior to the study
研究者
相似试验
已完成
不适用
Metabolism of long-chain polyunsaturated fatty acids and oxylipinsPrevention of civilization diseasesDRKS00011199niversität HannoverInstitut für Lebensmittelwissenschaft und Humanernährung15
撤回
不适用
Regional Fatty Acid Metabolism in HumansDiabetes Mellitus, Type 2NCT00068887Mayo Clinic
尚未招募
不适用
Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic ConditionsAtherosclerosis Cardiovascular DiseaseNCT06731400University of Sao Paulo6
尚未招募
Unknown
A clinical trial to study the effect of diet and intestinal micro-organisms on type 2 diabetes mellitusCTRI/2023/10/059154Manipal Academy of Higher Education MAHE
已完成
不适用
Microbiome Characteristics and short-chain FATty acid metabolism in type 1 diabetes patients versus healthy controlstype 1 diabetes mellitusintestinal microbiomeintestinal permeability (calprotectin)inflammatory toneNL-OMON24800AMC-UvA60